Catalent Pharma Solutions is building up its clinical supply capabilities in Asia, expanding a Singapore facility as it works on a sizable expansion in Japan.
CRO giant Quintiles posted another $1 billion revenue quarter on the way to a record year, but the company is narrowing its sales projections over ongoing foreign exchange issues. Read more >>
POPULAR COMMENT THREADS
The Michael J. Fox Foundation awarded a grant to Evotec to support the company's work in Parkinson's disease, bankrolling a project meant to clear the way for new therapies.
Catalent Pharma Solutions remained stagnant in its fiscal second quarter, as global currency fluctuations undid baseline growth in its banner businesses.
Contract drugmaker Recipharm is promising to spend $45 million (€40 million) over the next three years to improve drug traceability in an effort to comply with new regulations and combat the rise of fake medicines.
Quintiles, the world's largest CRO, is expecting its revenue to jump as much as 8.5% in 2016 on the heels of a record year.
Icon has become the first contract research company to help manage the reams of big data coming from the U.K.'s unique private-public partnership Genomics England.
Beijing, China-based contract research organization Pharmaron has snapped up fellow CRO Quotient Bioresearch as it looks to broaden its reach both technically and geographically.
From Our Sister Sites
Pfizer Consumer Healthcare announced the launch of joint health and wellness innovation program that will enable 10 med tech startups to utilize the San Francisco office of tech industry incubator Galvanize.
India's Sun Pharmaceutical saw its sales in the U.S., its largest market, continue to fall as problems with a key plant in India have yet to be resolved. U.S. sales were off 11% to $486 million in the quarter ended Dec. 31, 2015, India's largest drugmaker reported today.